180 results
6-K
EX-99.2
SNY
Sanofi
11 Dec 20
Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in the elderly
3:25pm
Exhibit 99.2
Press Release
Source: Sanofi (EURONEXT: SAN) (NASDAQ: SNY)
Sanofi pioneers sustainable finance in the pharmaceutical industry … in sustainability-linked credit facilities.
PARIS – December 9, 2020—Sanofi pioneers sustainable finance in the pharmaceutical industry with the signing
6-K
EX-99.1
SNY
Sanofi
8 Jul 22
Sanofi Global Health launches nonprofit Impact® brand for 30 medicines in low-income countries
11:01am
insulin, to be available in 40 lower-income countries
Investment fund established to help create sustainable health systems
Announcements comes … the establishment of an Impact fund that will support startup companies and other innovators that can deliver scalable solutions for sustainable healthcare
6-K
EX-99.3
SNY
Sanofi
20 Oct 23
Late-breaking amlitelimab Phase 2b data presented at EADV show potential best-in-class profile in atopic dermatitis
2:31pm
and sustainable access to quality medicines, vaccines and healthcare for underserved populations.
Sanofi’s social model to broaden access … medicines and sustainable healthcare to people in the 40 most underserved countries is not a simple task. It requires cross-sector partnerships
425
GZTR
Genzyme Corp
16 Feb 11
Business combination disclosure
12:00am
Commission File No: 0-14680
The following investor presentation, entitled “Adding a New Global Platform to our Sustainable Growth Strategy” was made … of Merger, dated as of February 16, 2011, among sanofi-aventis, GC Merger Corp., and Genzyme.
Adding a New Global Platform
to our Sustainable Growth
425
Aventis
5 Feb 04
Business combination disclosure
12:00am
to improving healthcare and capable of driving
strong, sustainable and profitable growth.
SANOFI-SYNTHELABO'S OFFER TO AVENTIS'S … in Europe and No.3 worldwide)
committed to improving healthcare and capable of driving strong, sustainable and
profitable growth
6-K
EX-99.1
2ddhlcuo9i 0e
18 Dec 20
Sanofi renews partnership with the WHO to fight Neglected Tropical Diseases and eliminate sleeping sickness before 2030
2:13pm
425
xrf00184bwf
2 Feb 04
Business combination disclosure
12:00am
425
z9z9u6t lscvxhg5
5 Feb 04
Business combination disclosure
12:00am
425
ivmq6hk qik
6 Feb 04
Business combination disclosure
12:00am
6-K
EX-99.3
mc55d
8 Jun 21
Sanofi launches its new global employee share ownership plan
1:31pm
425
jfe95x1imwl7
9 Feb 04
Business combination disclosure
12:00am
6-K
EX-99.1
m2rbe
31 Mar 22
Current report (foreign)
12:12pm
6-K
597rln5 ky6trrbio
11 Dec 20
Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in the elderly
3:25pm
6-K
EX-99.2
3drpx 6k7
6 Mar 20
Filing of the 2019 U.S. Form20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
1:02pm
425
r8296j2b
16 Feb 11
Business combination disclosure
12:00am
6-K
EX-99.1
ca2byww5sxwyc3as 1b
30 Aug 10
Current report (foreign)
12:00am
425
7v8 y62rd
19 Feb 04
Business combination disclosure
12:00am
425
kldxce40ny7osd8rm
26 Jan 04
Business combination disclosure
12:00am